Dotmatics Limited

Dotmatics Limited

January 14, 2010 02:05 ET

Dotmatics Licenses Its Suite of Tools to the Institute of Cancer Research

BISHOPS STORTFORD, UNITED KINGDOM--(Marketwire - Jan. 14, 2010) - Dotmatics is pleased to announce that it has licensed its enterprise query, reporting, registration and data management tools to The Institute of Cancer Research (ICR). The solution will primarily be used in the Cancer Research UK Centre for Cancer Therapeutics to query, browse, analyze and share chemical, biological and drug metabolism information across research programs and project teams. Dotmatics and the ICR will work closely together to identify and develop new tools to help progress scientific efforts, especially those applicable to research into the causes, prevention, diagnosis and methods of treatment of cancer.

Stephen Gallagher, Chief Executive Officer of Dotmatics, said: "We began working with the ICR last year when it chose Dotmatics above other providers for research tools in the Cancer Research UK Centre for Cancer Therapeutics. We are immensely proud to be working with such a prestigious organization and look forward to a close and fruitful relationship with the ICR and its partners."

Professor Julian Blagg, Head of Medicinal Chemistry at the Centre for Cancer Therapeutics said: "Dotmatics was chosen as our preferred partner to meet our chemoinformatics needs; the cost effectiveness and flexibility of the Dotmatics solution are particularly important to us. The Dotmatics team have been very helpful in the implementation of the platform across our centre and we look forward to working with Dotmatics to develop and integrate new chemoinformatics tools to assist our cancer drug discovery work."

About Dotmatics

By enabling discovery organizations to share and use their research information more efficiently, the company's aims are to facilitate the generation of strategic knowledge, making the right information available to the right person, at the right time and to boost customers' productivity by maximizing their information and knowledge awareness across the spectrum of their discovery activities.

Some product highlights:

Browser - web-based tool for querying, browsing and visualizing biological databases such as IDBS' ActivityBase and any chemical database.

Vortex - world-class visualization and analytics platform for scientific and non-scientific data.

Gateway - securely enables research teams to share information internally and with external partners.

Pinpoint - powerful Oracle chemical cartridge for querying and integrating chemical databases(i). Pinpoint represents world-class indexing and search performance at a cost-effective price.

Register - flexible and scalable chemical registration system.

Nucleus - map and import biological and non-biological data files into an Oracle database.

Studies - the new standard in screening data management.

About The Institute of Cancer Research

- The ICR is Europe's leading cancer research centre

- The ICR has been ranked the UK's top academic research centre, based on the results of the Higher Education Funding Council's Research Assessment Exercise

- The ICR works closely with partner The Royal Marsden NHS Foundation Trust to ensure patients immediately benefit from new research. Together the two organisations form the largest comprehensive cancer centre in Europe

- The ICR has charitable status and relies on voluntary income, spending 95 pence in every pound of total income directly on research

- As a college of the University of London, the ICR also provides postgraduate higher education of international distinction

- Over its 100-year history, the ICR's achievements include identifying the potential link between smoking and lung cancer which was subsequently confirmed, discovering that DNA damage is the basic cause of cancer and isolating more cancer-related genes than any other organisation in the world

- The ICR is home to the world's leading academic drug development team, the Centre for Cancer Therapeutics. Several important anti-cancer drugs used worldwide were synthesised at the ICR and it has discovered an average of two preclinical candidates each year over the past five years.

For more information visit www.icr.ac.uk

About Cancer Research UK

- Cancer Research UK is the world's leading charity dedicated to beating cancer through research.

- The charity's groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public.

- Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last thirty years.

- Cancer Research UK supports research into all aspects of cancer through the work of more than 4,800 scientists, doctors and nurses.

- Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.

For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7121 6699 or visit www.cancerresearchuk.org

(i) Developed in collaboration with Astex Therapeutics.

Enquiries


Europe:
1-2 Thorley Hall Stables
Bishops Stortford
Hertfordshire
CM23 4BE
UK
Tel: +44(0)1279 654 123 / Fax: +44(0)1279 653 088

North America:
12526 High Bluff Drive
Suite 300
San Diego, CA 92130
USA
Tel: +1 619 419 2808

Contact Information